Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Thoracic Surgery

  Free Subscription


Articles published in J Heart Lung Transplant

Retrieve available abstracts of 130 articles:
HTML format
Text format



Single Articles


    October 2017
  1. SEE VY
    Organized atrial arrhythmias after cardiac transplantation: The overlooked value of the 12-lead electrocardiogram and cavotricuspid atrial flutter isthmus.
    J Heart Lung Transplant. 2017 Oct 27. pii: S1053-2498(17)32084.
    PubMed     Text format    


  2. SNELL GI, Yusen RD, Weill D, Strueber M, et al
    Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: Definition and grading-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation.
    J Heart Lung Transplant. 2017;36:1097-1103.
    PubMed     Text format    


    September 2017
  3. AIGNER C, Slama A, Barta M, Mitterbauer A, et al
    Treatment of primary graft dysfunction after lung transplantation with orally inhaled AP301: A prospective, randomized pilot study.
    J Heart Lung Transplant. 2017 Sep 30. pii: S1053-2498(17)32036.
    PubMed     Text format     Abstract available


    August 2017
  4. GLASS L, Savage A, Haddad O, Kavarana MN, et al
    Continuous-flow, implantable biventricular assist device as bridge to cardiac transplantation in a small child with restrictive cardiomyopathy.
    J Heart Lung Transplant. 2017 Aug 10. pii: S1053-2498(17)31946.
    PubMed     Text format    


    July 2017
  5. DIAMOND JM, Arcasoy S, Kennedy CC, Eberlein M, et al
    Report of the International Society for Heart and Lung Transplantation Working Group on Primary Lung Graft Dysfunction, part II: Epidemiology, risk factors, and outcomes-A 2016 Consensus Group statement of the International Society for Heart and Lung
    J Heart Lung Transplant. 2017 Jul 26. pii: S1053-2498(17)31922.
    PubMed     Text format    


  6. GELMAN AE, Fisher AJ, Huang HJ, Baz MA, et al
    Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part III: Mechanisms: A 2016 Consensus Group Statement of the International Society for Heart and Lung Transplantation.
    J Heart Lung Transplant. 2017 Jul 24. pii: S1053-2498(17)31905.
    PubMed     Text format    


  7. VAN RAEMDONCK D, Hartwig MG, Hertz MI, Davis RD, et al
    Report of the ISHLT Working Group on primary lung graft dysfunction Part IV: Prevention and treatment: A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation.
    J Heart Lung Transplant. 2017 Jul 21. pii: S1053-2498(17)31904.
    PubMed     Text format    


  8. SHAH SZ, Pouch SM, Keller BC, Pope-Harman A, et al
    Outcomes from bacteremic donors in lung transplantation.
    J Heart Lung Transplant. 2017 Jul 21. pii: S1053-2498(17)31925.
    PubMed     Text format    


  9. LUND LH, Khush KK, Cherikh WS, Goldfarb S, et al
    The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time.
    J Heart Lung Transplant. 2017 Jul 20. pii: S1053-2498(17)31910.
    PubMed     Text format    


  10. ROSSANO JW, Cherikh WS, Chambers DC, Goldfarb S, et al
    The Registry of the International Society for Heart and Lung Transplantation: Twentieth Pediatric Heart Transplantation Report-2017; Focus Theme: Allograft Ischemic Time.
    J Heart Lung Transplant. 2017 Jul 20. pii: S1053-2498(17)31909.
    PubMed     Text format    


  11. CHAMBERS DC, Yusen RD, Cherikh WS, Goldfarb SB, et al
    The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time.
    J Heart Lung Transplant. 2017 Jul 19. pii: S1053-2498(17)31907.
    PubMed     Text format    


  12. GOLDFARB SB, Levvey BJ, Cherikh WS, Chambers DC, et al
    Registry of the International Society for Heart and Lung Transplantation: Twentieth Pediatric Lung and Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time.
    J Heart Lung Transplant. 2017 Jul 19. pii: S1053-2498(17)31908.
    PubMed     Text format    


  13. VIETZEN H, Gorzer I, Honsig C, Jaksch P, et al
    Association between antibody functions and human cytomegalovirus (HCMV) replication after lung transplantation in HCMV-seropositive patients.
    J Heart Lung Transplant. 2017 Jul 18. pii: S1053-2498(17)31901.
    PubMed     Text format    


  14. LEUSCHNER G, Stocker F, Veit T, Kneidinger N, et al
    Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy.
    J Heart Lung Transplant. 2017 Jul 5. pii: S1053-2498(17)31886.
    PubMed     Text format     Abstract available


  15. MULVIHILL MS, Yerokun BA, Davis RP, Ranney DN, et al
    Extracorporeal membrane oxygenation following lung transplantation: indications and survival.
    J Heart Lung Transplant. 2017 Jul 1. pii: S1053-2498(17)31880.
    PubMed     Text format     Abstract available


    June 2017
  16. SWEET SC
    Assessing the impact of program volume and composition on waiting list outcomes in pediatric lung transplantation.
    J Heart Lung Transplant. 2017 Jun 21. pii: S1053-2498(17)31871.
    PubMed     Text format    


  17. HASHIMOTO K, Cypel M, Juvet S, Saito T, et al
    Higher M30 and high mobility group box 1 protein levels in ex vivo lung perfusate are associated with primary graft dysfunction after human lung transplantation.
    J Heart Lung Transplant. 2017 Jun 21. pii: S1053-2498(17)31870.
    PubMed     Text format     Abstract available


    May 2017
  18. VERLEDEN GM, Vos R
    Statins in lung transplantation: A treatment option for every patient?
    J Heart Lung Transplant. 2017 May 25. pii: S1053-2498(17)31810.
    PubMed     Text format    


  19. RAPHAEL J, Collins SR, Wang XQ, Scalzo DC, et al
    Perioperative statin use is associated with decreased incidence of primary graft dysfunction after lung transplantation.
    J Heart Lung Transplant. 2017 May 6. pii: S1053-2498(17)31783.
    PubMed     Text format     Abstract available


    April 2017
  20. SCULLY BB, Goss M, Liu H, Keuht ML, et al
    Waitlist outcomes in pediatric lung transplantation: Poor results for children listed in adult transplant programs.
    J Heart Lung Transplant. 2017 Apr 24. pii: S1053-2498(17)31753.
    PubMed     Text format     Abstract available


    March 2017
  21. BLATTER JA
    Hard to swallow? Dysmotility, reflux and chronic lung allograft dysfunction in pediatric lung transplantation.
    J Heart Lung Transplant. 2017 Mar 20. pii: S1053-2498(17)31709.
    PubMed     Text format    


  22. VOS R, Ruttens D, Verleden SE, Vandermeulen E, et al
    High-dose vitamin D after lung transplantation: A randomized trial.
    J Heart Lung Transplant. 2017 Mar 8. pii: S1053-2498(17)31685.
    PubMed     Text format     Abstract available


    February 2017
  23. COURTWRIGHT A, El-Chemaly S
    Broadening the investigation-short telomeres and lung transplantation outcomes in pulmonary fibrosis.
    J Heart Lung Transplant. 2017 Feb 28. pii: S1053-2498(17)31650.
    PubMed     Text format    


  24. SABATINO M, Vitale G, Manfredini V, Masetti M, et al
    Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes.
    J Heart Lung Transplant. 2017 Feb 17. pii: S1053-2498(17)31623.
    PubMed     Text format     Abstract available


  25. PARASKEVA MA, Edwards LB, Levvey B, Stehlik J, et al
    Outcomes of adolescent recipients after lung transplantation: An analysis of the International Society for Heart and Lung Transplantation Registry.
    J Heart Lung Transplant. 2017 Feb 17. pii: S1053-2498(17)31626.
    PubMed     Text format     Abstract available


  26. NEWTON CA, Kozlitina J, Lines JR, Kaza V, et al
    Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival.
    J Heart Lung Transplant. 2017 Feb 4. pii: S1053-2498(17)31352.
    PubMed     Text format     Abstract available


  27. FERNANDEZ-BUSSY S, Labarca G, Majid A
    In reply: Biodegradable stent for vanishing bronchus syndrome after lung transplantation.
    J Heart Lung Transplant. 2017 Feb 3. pii: S1053-2498(17)31351.
    PubMed     Text format    


    January 2017
  28. GOTTLIEB J, Fuehner T, Greer M
    Biodegradable stent for vanishing bronchus syndrome after lung transplantation.
    J Heart Lung Transplant. 2017 Jan 5. pii: S1053-2498(17)30013.
    PubMed     Text format    


    December 2016
  29. COURTWRIGHT AM, El-Chemaly S, Dellaripa PF, Goldberg HJ, et al
    Survival and outcomes after lung transplantation for non-scleroderma connective tissue-related interstitial lung disease.
    J Heart Lung Transplant. 2016 Dec 31. pii: S1053-2498(16)30492.
    PubMed     Text format     Abstract available


  30. GODA Y, Motoyama H, Aoyama A, Hamaji M, et al
    Right-to-left inverted living-donor lobar lung transplantation combined with sparing of native right upper lobe.
    J Heart Lung Transplant. 2016 Dec 20. pii: S1053-2498(16)30444.
    PubMed     Text format    


  31. RAJAGOPAL K, Hoeper MM
    State of the Art: Bridging to lung transplantation using artificial organ support technologies.
    J Heart Lung Transplant. 2016;35:1385-1398.
    PubMed     Text format     Abstract available


    November 2016
  32. FERNANDEZ-BUSSY S, Labarca G, Majid A
    Biodegradable stent for vanishing bronchus syndrome after lung transplantation.
    J Heart Lung Transplant. 2016;35:1378-1379.
    PubMed     Text format    


    October 2016
  33. GORZER I, Jaksch P, Strassl R, Klepetko W, et al
    Association between plasma Torque teno virus level and chronic lung allograft dysfunction after lung transplantation.
    J Heart Lung Transplant. 2016 Oct 21. pii: S1053-2498(16)30386.
    PubMed     Text format    


  34. LANCASTER TS, Miller JR, Epstein DJ, DuPont NC, et al
    Improved waitlist and transplant outcomes for pediatric lung transplantation after implementation of the lung allocation score.
    J Heart Lung Transplant. 2016 Oct 17. pii: S1053-2498(16)30365.
    PubMed     Text format     Abstract available


  35. MCILVENNAN CK
    Looking on the BRIGHT side of health literacy in patients with cardiac transplantation: Where are we and where do we need to go?
    J Heart Lung Transplant. 2016 Oct 13. pii: S1053-2498(16)30347.
    PubMed     Text format    


  36. MOLLBERG NM, Howell E, Vanderhoff DI, Cheng A, et al
    Health care utilization and consequences of readmission in the first year after lung transplantation.
    J Heart Lung Transplant. 2016 Oct 7. pii: S1053-2498(16)30343.
    PubMed     Text format     Abstract available


  37. GOLDFARB SB, Levvey BJ, Edwards LB, Dipchand AI, et al
    The Registry of the International Society for Heart and Lung Transplantation: Nineteenth Pediatric Lung and Heart-Lung Transplantation Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant.
    J Heart Lung Transplant. 2016;35:1196-1205.
    PubMed     Text format    


  38. ROSSANO JW, Dipchand AI, Edwards LB, Goldfarb S, et al
    The Registry of the International Society for Heart and Lung Transplantation: Nineteenth Pediatric Heart Transplantation Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant.
    J Heart Lung Transplant. 2016;35:1185-1195.
    PubMed     Text format    


  39. YUSEN RD, Edwards LB, Dipchand AI, Goldfarb SB, et al
    The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart-Lung Transplant Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant.
    J Heart Lung Transplant. 2016;35:1170-1184.
    PubMed     Text format    


  40. LUND LH, Edwards LB, Dipchand AI, Goldfarb S, et al
    The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant.
    J Heart Lung Transplant. 2016;35:1158-1169.
    PubMed     Text format    


    September 2016
  41. GOLDBERG HJ
    Maintaining airway integrity after lung transplantation-Could an ounce of prevention be worth a pound of cure?
    J Heart Lung Transplant. 2016 Sep 13. pii: S1053-2498(16)30317.
    PubMed     Text format    


  42. XU Z, Sharma M, Gelman A, Hachem R, et al
    Significant role for microRNA-21 affecting toll-like receptor pathway in primary graft dysfunction after human lung transplantation.
    J Heart Lung Transplant. 2016 Sep 12. pii: S1053-2498(16)30316.
    PubMed     Text format     Abstract available


  43. HAYES D JR, Reynolds SD, Tumin D
    Outcomes of lung transplantation for primary ciliary dyskinesia and Kartagener syndrome.
    J Heart Lung Transplant. 2016 Sep 7. pii: S1053-2498(16)30313.
    PubMed     Text format    


    August 2016
  44. WEVER-PINZON O, Edwards LB, Taylor DO, Kfoury AG, et al
    Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry.
    J Heart Lung Transplant. 2016 Aug 20. pii: S1053-2498(16)30289.
    PubMed     Text format     Abstract available


  45. LEARD LE
    Lung transplantation after prior cardiothoracic surgery: To transplant or not to transplant.
    J Heart Lung Transplant. 2016 Aug 20. pii: S1053-2498(16)30288.
    PubMed     Text format    


  46. OLLAND A, Reeb J, Puyraveau M, Hirschi S, et al
    Bronchial complications after lung transplantation are associated with primary lung graft dysfunction and surgical technique.
    J Heart Lung Transplant. 2016 Aug 17. pii: S1053-2498(16)30284.
    PubMed     Text format     Abstract available


  47. BANGA A, Mohanka M, Mullins J, Bollineni S, et al
    Hospital length of stay after lung transplantation: Independent predictors and association with early and late survival.
    J Heart Lung Transplant. 2016 Aug 11. pii: S1053-2498(16)30281.
    PubMed     Text format     Abstract available


    July 2016
  48. JAVAHERI A, Molina M, Zamani P, Rodrigues A, et al
    Cholesterol efflux capacity of high-density lipoprotein correlates with survival and allograft vasculopathy in cardiac transplant recipients.
    J Heart Lung Transplant. 2016 Jul 15. pii: S1053-2498(16)30216.
    PubMed     Text format     Abstract available


  49. DIAZ-GUZMAN E, Sharma NS, Wille K, Hoopes CW, et al
    Use of a novel pulmonary artery cannula to provide extracorporeal membrane oxygenation as a bridge to lung transplantation.
    J Heart Lung Transplant. 2016 Jul 1. pii: S1053-2498(16)30141.
    PubMed     Text format    


    June 2016
  50. RAGHAVAN D, Gao A, Ahn C, Kaza V, et al
    Lung transplantation and gender effects on survival of recipients with cystic fibrosis.
    J Heart Lung Transplant. 2016 Jun 24. pii: S1053-2498(16)30191.
    PubMed     Text format     Abstract available


  51. MCDIARMID AK, Plein S, Ross HJ
    Emerging imaging techniques after cardiac transplantation.
    J Heart Lung Transplant. 2016 Jun 24. pii: S1053-2498(16)30195.
    PubMed     Text format     Abstract available


  52. MCKELLAR SH, Bowen ME, Baird BC, Raman S, et al
    Lung transplantation following coronary artery bypass surgery-improved outcomes following single-lung transplant.
    J Heart Lung Transplant. 2016 Jun 14. pii: S1053-2498(16)30174.
    PubMed     Text format     Abstract available


  53. OMARA M, Okamoto T, Arafat A, Thuita L, et al
    Lung transplantation in patients who have undergone prior cardiothoracic procedures.
    J Heart Lung Transplant. 2016 Jun 14. pii: S1053-2498(16)30175.
    PubMed     Text format     Abstract available


  54. VOGL M, Warnecke G, Haverich A, Gottlieb J, et al
    Lung transplantation in the spotlight: Reasons for high-cost procedures.
    J Heart Lung Transplant. 2016 Jun 7. pii: S1053-2498(16)30165.
    PubMed     Text format     Abstract available


  55. KIMURA N, Khan MS, Schecter M, Rizwan R, et al
    Changing demographics and outcomes of lung transplantation recipients with cystic fibrosis.
    J Heart Lung Transplant. 2016 Jun 7. pii: S1053-2498(16)30166.
    PubMed     Text format     Abstract available


    May 2016
  56. LE PAVEC J, Suberbielle C, Lamrani L, Feuillet S, et al
    De-novo donor-specific anti-HLA antibodies 30 days after lung transplantation are associated with a worse outcome.
    J Heart Lung Transplant. 2016 May 31. pii: S1053-2498(16)30145.
    PubMed     Text format     Abstract available


  57. HAYES D, Joy BF, Reynolds SD, Tobias JD, et al
    Influence of graft ischemic time and geographic distance between donor and recipient on survival in children after lung transplantation.
    J Heart Lung Transplant. 2016 May 27. pii: S1053-2498(16)30143.
    PubMed     Text format     Abstract available


  58. WALSH JR, Chambers DC, Yerkovich ST, Hopkins PM, et al
    Low levels of physical activity predict worse survival to lung transplantation and poor early post-operative outcomes.
    J Heart Lung Transplant. 2016 May 20. pii: S1053-2498(16)30138.
    PubMed     Text format    


  59. NAU M, Shrider EA, Tobias JD, Hayes D Jr, et al
    High local unemployment rates limit work after lung transplantation.
    J Heart Lung Transplant. 2016 May 16. pii: S1053-2498(16)30127.
    PubMed     Text format     Abstract available


  60. EBERLEIN M
    Excessive dynamic airway collapse and lung transplantation.
    J Heart Lung Transplant. 2016 May 16. pii: S1053-2498(16)30128.
    PubMed     Text format    


  61. FREEMAN N, Le LW, Singer LG, Colman R, et al
    Impact of a transplant palliative care clinic on symptoms for patients awaiting lung transplantation.
    J Heart Lung Transplant. 2016 May 16. pii: S1053-2498(16)30131.
    PubMed     Text format    


  62. VARR BC, Restaino SW, Farr M, Scully B, et al
    Infectious complications after cardiac transplantation in patients bridged with mechanical circulatory support devices versus medical therapy.
    J Heart Lung Transplant. 2016 May 11. pii: S1053-2498(16)30120.
    PubMed     Text format     Abstract available


  63. TOMASKO J, Prasad SM, Dell DO, DeCamp MM, et al
    Therapeutic anticoagulation-free extracorporeal membrane oxygenation as a bridge to lung transplantation.
    J Heart Lung Transplant. 2016 May 6. pii: S1053-2498(16)30108.
    PubMed     Text format    


  64. HAYES D JR, Glanville AR, McGiffin D, Tobias JD, et al
    Age-related survival disparity associated with lung transplantation in cystic fibrosis: An analysis of the registry of the International Society for Heart and Lung Transplantation.
    J Heart Lung Transplant. 2016 May 6. pii: S1053-2498(16)30119.
    PubMed     Text format     Abstract available


  65. VAN BESOUW NM, van Hal PT, Zuijderwijk JM, de Kuiper R, et al
    Herpes zoster after lung transplantation boosts varicella zoster virus-specific adaptive immune responses.
    J Heart Lung Transplant. 2016 May 6. pii: S1053-2498(16)30113.
    PubMed     Text format     Abstract available


  66. AWORI HAYANGA JW, Aboagye JK, Shigemura N, Hayanga HK, et al
    Airway complications after lung transplantation: Contemporary survival and outcomes.
    J Heart Lung Transplant. 2016 May 6. pii: S1053-2498(16)30123.
    PubMed     Text format     Abstract available


    April 2016
  67. VERLEDEN SE, Ruttens D, Vandermeulen E, Bellon H, et al
    Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation.
    J Heart Lung Transplant. 2016 Apr 16. pii: S1053-2498(16)30096.
    PubMed     Text format     Abstract available


  68. XU Z, Ramachandran S, Gunasekaran M, Zhou F, et al
    MicroRNA-144 is unlikely to play a role in bronchiolitis obliterans syndrome.
    J Heart Lung Transplant. 2016;35:543-4.
    PubMed     Text format    


  69. HALUSHKA MK
    MicroRNA-144 is unlikely to play a role in bronchiolitis obliterans syndrome.
    J Heart Lung Transplant. 2016;35:543.
    PubMed     Text format    


  70. SCHREPFER S, Cantu E, Gandy K, Baan CC, et al
    "Bioengineered lungs" Best science paper in JHLT 2014-2015.
    J Heart Lung Transplant. 2016;35:544-6.
    PubMed     Text format    


  71. SEIDELMANN SB, Laur O, Hwa J, Depasquale E, et al
    Familial dilated cardiomyopathy diagnosis is commonly overlooked at the time of transplant listing.
    J Heart Lung Transplant. 2016;35:474-80.
    PubMed     Text format     Abstract available


  72. SHEHAB S, Macdonald PS, Keogh AM, Kotlyar E, et al
    Long-term biventricular HeartWare ventricular assist device support--Case series of right atrial and right ventricular implantation outcomes.
    J Heart Lung Transplant. 2016;35:466-73.
    PubMed     Text format     Abstract available


  73. OISHI H, Martinu T, Sato M, Matsuda Y, et al
    Halofuginone treatment reduces interleukin-17A and ameliorates features of chronic lung allograft dysfunction in a mouse orthotopic lung transplant model.
    J Heart Lung Transplant. 2016;35:518-27.
    PubMed     Text format     Abstract available


  74. YAMADA Y, Jang JH, De Meester I, Baerts L, et al
    CD26 costimulatory blockade improves lung allograft rejection and is associated with enhanced interleukin-10 expression.
    J Heart Lung Transplant. 2016;35:508-17.
    PubMed     Text format     Abstract available


    March 2016
  75. DALY KP
    Finding the correct role for heart transplant in the treatment of hypoplastic left heart syndrome.
    J Heart Lung Transplant. 2016;35:299-300.
    PubMed     Text format    


  76. HAMMOND ME, Revelo MP, Miller DV, Snow GL, et al
    ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis.
    J Heart Lung Transplant. 2016;35:320-5.
    PubMed     Text format     Abstract available


  77. PECHA S, Eschenhagen T, Reichenspurner H
    Myocardial tissue engineering for cardiac repair.
    J Heart Lung Transplant. 2016;35:294-8.
    PubMed     Text format     Abstract available


  78. SUN Y, Jin X, Liu X, Zhang M, et al
    MicroRNA let-7i regulates dendritic cells maturation targeting interleukin-10 via the Janus kinase 1-signal transducer and activator of transcription 3 signal pathway subsequently induces prolonged cardiac allograft survival in rats.
    J Heart Lung Transplant. 2016;35:378-88.
    PubMed     Text format     Abstract available


    February 2016
  79. REINSMOEN NL, Patel J, Mirocha J, Lai CH, et al
    Optimizing transplantation of sensitized heart candidates using 4 antibody detection assays to prioritize the assignment of unacceptable antigens.
    J Heart Lung Transplant. 2016;35:165-72.
    PubMed     Text format     Abstract available


  80. TAGHAVI S, Jayarajan SN, Komaroff E, Mangi AA, et al
    Right ventricular assist device results in worse post-transplant survival.
    J Heart Lung Transplant. 2016;35:236-41.
    PubMed     Text format     Abstract available


  81. ZALAWADIYA SK, Wigger M, DiSalvo T, Haglund N, et al
    Mechanical circulatory support and simultaneous heart-kidney transplantation: An outcome analysis.
    J Heart Lung Transplant. 2016;35:203-12.
    PubMed     Text format     Abstract available


  82. HAYES D JR, Black SM, Tobias JD, Kopp BT, et al
    Influence of human leukocyte antigen mismatching on bronchiolitis obliterans syndrome in lung transplantation.
    J Heart Lung Transplant. 2016;35:186-94.
    PubMed     Text format     Abstract available


  83. GOTTLIEB J, Zamora MR, Hodges T, Musk AW, et al
    ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients.
    J Heart Lung Transplant. 2016;35:213-21.
    PubMed     Text format     Abstract available


  84. SEILER A, Klaghofer R, Ture M, Komossa K, et al
    A systematic review of health-related quality of life and psychological outcomes after lung transplantation.
    J Heart Lung Transplant. 2016;35:195-202.
    PubMed     Text format     Abstract available


    January 2016
  85. LAL AK, Pruitt E, Hong BJ, Lin KY, et al
    Left ventricular non-compaction cardiomyopathy in children listed for heart transplant: Analysis from the Pediatric Heart Transplant Study Group.
    J Heart Lung Transplant. 2016 Jan 6. pii: S1053-2498(16)00005.
    PubMed     Text format    


  86. URSCHEL S, Ryan LA, M Larsen I, Biffis K, et al
    Development of B-cell memory in early childhood and the impact on antigen-specific tolerance after heart transplantation.
    J Heart Lung Transplant. 2016 Jan 6. pii: S1053-2498(16)00004.
    PubMed     Text format     Abstract available


  87. WALLACE WD, Li N, Andersen CB, Arrossi AV, et al
    Banff study of pathologic changes in lung allograft biopsy specimens with donor-specific antibodies.
    J Heart Lung Transplant. 2016;35:40-8.
    PubMed     Text format     Abstract available


  88. DARLEY DR, Malouf MA, Glanville AR
    A rare case of everolimus-induced pulmonary alveolar proteinosis.
    J Heart Lung Transplant. 2016;35:147-8.
    PubMed     Text format    


  89. GUZMAN-PRUNEDA FA, Orr Y, Trost JG, Zhang W, et al
    Bronchial artery revascularization and en bloc lung transplant in children.
    J Heart Lung Transplant. 2016;35:122-9.
    PubMed     Text format     Abstract available


  90. NOGUCHI R, Nakayama K, Itoh M, Kamohara K, et al
    Development of a three-dimensional pre-vascularized scaffold-free contractile cardiac patch for treating heart disease.
    J Heart Lung Transplant. 2016;35:137-45.
    PubMed     Text format     Abstract available


  91. SAITO T, Horie M, Sato M, Nakajima D, et al
    Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
    J Heart Lung Transplant. 2016;35:59-66.
    PubMed     Text format     Abstract available


  92. HSIN MK, Iskender I, Nakajima D, Chen M, et al
    Extension of donor lung preservation with hypothermic storage after normothermic ex vivo lung perfusion.
    J Heart Lung Transplant. 2016;35:130-6.
    PubMed     Text format     Abstract available


  93. ROSS HJ
    The ethics of risk and innovation.
    J Heart Lung Transplant. 2016;35:24-5.
    PubMed     Text format    


  94. IUS F, Sommer W, Tudorache I, Avsar M, et al
    Five-year experience with intraoperative extracorporeal membrane oxygenation in lung transplantation: Indications and midterm results.
    J Heart Lung Transplant. 2016;35:49-58.
    PubMed     Text format     Abstract available


  95. CHAIKRIANGKRAI K, Jyothula S, Jhun HY, Estep J, et al
    Impact of pre-operative coronary artery disease on cardiovascular events following lung transplantation.
    J Heart Lung Transplant. 2016;35:115-21.
    PubMed     Text format     Abstract available


    November 2015
  96. GREENWAY SC, Butts R, Naftel DC, Pruitt E, et al
    Statin therapy is not associated with improved outcomes after heart transplantation in children and adolescents.
    J Heart Lung Transplant. 2015 Nov 22. pii: S1053-2498(15)01517.
    PubMed     Text format     Abstract available


  97. SIMON B, Weseslindtner L, Gorzer I, Pollak K, et al
    Subclass-specific antibody responses to human cytomegalovirus in lung transplant recipients and their association with constant heavy immunoglobulin G chain polymorphism and virus replication.
    J Heart Lung Transplant. 2015 Nov 5. pii: S1053-2498(15)01487.
    PubMed     Text format     Abstract available


    October 2015
  98. CASTLEBERRY CD, Zafar F, Dipchand AI, Edwards L, et al
    Early initiation of mTOR inhibitors in children with heart transplantation: A propensity-based registry analysis.
    J Heart Lung Transplant. 2015 Oct 30. pii: S1053-2498(15)01486.
    PubMed     Text format    


  99. CARLO WF, West SC, McCulloch M, Naftel DC, et al
    Impact of initial Norwood shunt type on young hypoplastic left heart syndrome patients listed for heart transplant: A multi-institutional study.
    J Heart Lung Transplant. 2015 Oct 30. pii: S1053-2498(15)01493.
    PubMed     Text format     Abstract available


  100. KULKARNI A, Neugebauer R, Lo Y, Gao Q, et al
    Outcomes and risk factors for listing for heart transplantation after the Norwood procedure: An analysis of the Single Ventricle Reconstruction Trial.
    J Heart Lung Transplant. 2015 Oct 30. pii: S1053-2498(15)01494.
    PubMed     Text format     Abstract available


  101. KFOURY AG, Miller DV, Snow GL, Afshar K, et al
    Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations.
    J Heart Lung Transplant. 2015 Oct 23. pii: S1053-2498(15)01477.
    PubMed     Text format     Abstract available


  102. GREENWAY SC, Crossland DS, Hudson M, Martin SR, et al
    Fontan-associated liver disease: Implications for heart transplantation.
    J Heart Lung Transplant. 2015 Oct 19. pii: S1053-2498(15)01476.
    PubMed     Text format     Abstract available


  103. DEO SV, Al-Kindi SG, Altarabsheh SE, Hang D, et al
    Model for end-stage liver disease excluding international normalized ratio (MELD-XI) score predicts heart transplant outcomes: Evidence from the registry of the united network for organ sharing.
    J Heart Lung Transplant. 2015 Oct 9. pii: S1053-2498(15)01455.
    PubMed     Text format     Abstract available


  104. WARE AL, Malmberg E, Delgado JC, Hammond ME, et al
    The use of circulating donor specific antibody to predict biopsy diagnosis of antibody-mediated rejection and to provide prognostic value after heart transplantation in children.
    J Heart Lung Transplant. 2015 Oct 8. pii: S1053-2498(15)01453.
    PubMed     Text format     Abstract available


  105. EVANS JD, Pettit SJ, Goddard M, Lewis C, et al
    Alemtuzumab as a novel treatment for refractory giant cell myocarditis after heart transplantation.
    J Heart Lung Transplant. 2015 Oct 8. pii: S1053-2498(15)01456.
    PubMed     Text format    


  106. COLVIN M, Miranda-Herrera D, Gustafson SK, Heubner B, et al
    Impact of increased time at the highest urgency category on heart transplant outcomes for candidates with ventricular assist devices.
    J Heart Lung Transplant. 2015 Oct 8. pii: S1053-2498(15)01458.
    PubMed     Text format     Abstract available


    September 2015
  107. TOMAI F, De Luca L, Petrolini A, Di Vito L, et al
    Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.
    J Heart Lung Transplant. 2015 Sep 3. pii: S1053-2498(15)01386.
    PubMed     Text format     Abstract available


  108. TRAN A, Fixler D, Huang R, Meza T, et al
    Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation.
    J Heart Lung Transplant. 2015 Sep 3. pii: S1053-2498(15)01383.
    PubMed     Text format     Abstract available


  109. AL-KINDI SG, El-Assaad I, Abi Khalil C, Oliveira GH, et al
    Heart transplantation of Middle Eastern patients in the United States: A brief report from the UNOS database.
    J Heart Lung Transplant. 2015;34:1219-20.
    PubMed     Text format    


    July 2015
  110. HOUSTON BA, Kalathiya RJ, Stevens GR, Russell SD, et al
    One-and-done: Do left ventricular assist device patients on the transplant list really need frequent right heart catheterization assessments for pulmonary hypertension?
    J Heart Lung Transplant. 2015 Jul 29. pii: S1053-2498(15)01366.
    PubMed     Text format    


  111. HEALY AH, Stehlik J, Edwards LB, McKellar SH, et al
    Predictors of 30-day post-transplant mortality in patients bridged to transplantation with continuous-flow left ventricular assist devices-an analysis of the international society for heart and lung transplantation transplant registry.
    J Heart Lung Transplant. 2015 Jul 29. pii: S1053-2498(15)01369.
    PubMed     Text format     Abstract available


  112. HEGEDUS P, Li S, Korkmaz-Icoz S, Radovits T, et al
    Dimethyloxalylglycine treatment of brain-dead donor rats improves both donor and graft left ventricular function after heart transplantation.
    J Heart Lung Transplant. 2015 Jul 4. pii: S1053-2498(15)01338.
    PubMed     Text format     Abstract available


    June 2015
  113. MONTANARI S, Dayan V, Yannarelli G, Billia F, et al
    Mesenchymal stromal cells improve cardiac function and left ventricular remodeling in a heart transplantation model.
    J Heart Lung Transplant. 2015 Jun 12. pii: S1053-2498(15)01279.
    PubMed     Text format     Abstract available


  114. LOGANATHAN S, Korkmaz-Icoz S, Radovits T, Li S, et al
    Effects of soluble guanylate cyclase activation on heart transplantation in a rat model.
    J Heart Lung Transplant. 2015 Jun 11. pii: S1053-2498(15)01277.
    PubMed     Text format     Abstract available


  115. DARE AJ, Logan A, Prime TA, Rogatti S, et al
    The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model.
    J Heart Lung Transplant. 2015 Jun 11. pii: S1053-2498(15)01278.
    PubMed     Text format     Abstract available


  116. GRIMM JC, Kilic A, Shah AS, Trent Magruder J, et al
    The influence of institutional volume on the incidence of complications and their effect on mortality after heart transplantation.
    J Heart Lung Transplant. 2015 Jun 10. pii: S1053-2498(15)01286.
    PubMed     Text format     Abstract available


  117. DAVIES RR, Haldeman S, McCulloch MA, Gidding SS, et al
    Low body mass index is associated with increased waitlist mortality among children listed for heart transplant.
    J Heart Lung Transplant. 2015 Jun 10. pii: S1053-2498(15)01297.
    PubMed     Text format     Abstract available


    May 2015
  118. ANSARI D, Lund LH, Stehlik J, Andersson B, et al
    Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab.
    J Heart Lung Transplant. 2015 May 2. pii: S1053-2498(15)01204.
    PubMed     Text format     Abstract available


    April 2015
  119. HERNANDEZ LE, Shepard CW, Menk J, Lilliam VC, et al
    Global left ventricular relaxation: A novel tissue Doppler index of acute rejection in pediatric heart transplantation.
    J Heart Lung Transplant. 2015 Apr 11. pii: S1053-2498(15)01185.
    PubMed     Text format     Abstract available


  120. LAKDAWALA NK
    Big data for a rare disease: Examining heart transplantation for left ventricular noncompaction in the United Network of Organ Sharing registry.
    J Heart Lung Transplant. 2015 Apr 4. pii: S1053-2498(15)01115.
    PubMed     Text format    


    March 2015
  121. SCHUMACHER KR, Gossett J, Guleserian K, Naftel DC, et al
    Fontan-associated protein-losing enteropathy and heart transplant: A Pediatric Heart Transplant Study analysis.
    J Heart Lung Transplant. 2015 Mar 30. pii: S1053-2498(15)01149.
    PubMed     Text format     Abstract available


  122. DELGADO JF, Reyne AG, de Dios S, Lopez-Medrano F, et al
    Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.
    J Heart Lung Transplant. 2015 Mar 26. pii: S1053-2498(15)01111.
    PubMed     Text format     Abstract available


  123. COUTANCE G, Ouldamar S, Rouvier P, Saheb S, et al
    Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy.
    J Heart Lung Transplant. 2015 Mar 20. pii: S1053-2498(15)01098.
    PubMed     Text format     Abstract available


    February 2015
  124. DALL CH, Gustafsson F, Christensen SB, Dela F, et al
    Effect of moderate- versus high-intensity exercise on vascular function, biomarkers and quality of life in heart transplant recipients: A randomized, crossover trial.
    J Heart Lung Transplant. 2015 Feb 7. pii: S1053-2498(15)01041.
    PubMed     Text format     Abstract available


  125. KHUU T, Cadeiras M, Wisniewski N, Reed EF, et al
    Reduced HLA Class II antibody response to proteasome inhibition in heart transplantation.
    J Heart Lung Transplant. 2015 Feb 7. pii: S1053-2498(15)01030.
    PubMed     Text format    


  126. POTENA L, Masetti M, Sabatino M, Bacchi-Reggiani ML, et al
    Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation.
    J Heart Lung Transplant. 2015 Feb 7. pii: S1053-2498(15)01038.
    PubMed     Text format     Abstract available


    December 2014
  127. MORRIS AA, Kalogeropoulos AP, Zhao L, Owen M, et al
    Race and ethnic differences in the epidemiology and risk factors for graft failure after heart transplantation.
    J Heart Lung Transplant. 2014 Dec 24. pii: S1053-2498(14)01507.
    PubMed     Text format     Abstract available


    November 2014
  128. JEEWA A, Chin C, Pahl E, Atz AM, et al
    Outcomes after percutaneous coronary artery revascularization procedures for cardiac allograft vasculopathy in pediatric heart transplant recipients: A multi-institutional study.
    J Heart Lung Transplant. 2014 Nov 15. pii: S1053-2498(14)01444.
    PubMed     Text format     Abstract available


  129. AL-KINDI SG, El-Amm C, Ginwalla M, Hoit BD, et al
    Heart transplant outcomes in patients with left ventricular non-compaction cardiomyopathy.
    J Heart Lung Transplant. 2014 Nov 8. pii: S1053-2498(14)01438.
    PubMed     Text format     Abstract available


  130. ROIG E, Almenar L, Crespo-Leiro M, Segovia J, et al
    Heart transplantation using allografts from older donors: Multicenter study results.
    J Heart Lung Transplant. 2014 Nov 4. pii: S1053-2498(14)01427.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: